| | | | Bartter disease type 1 | Pathogenic (Jul 12, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr15:48548031
- GRCh38:
- Chr15:48255834
| SLC12A1 | Q656* | Bartter disease type 1 | Pathogenic (Sep 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:48541844
- GRCh38:
- Chr15:48249647
| SLC12A1 | C586Y | Bartter disease type 1 | Uncertain significance (Feb 23, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr15:48539583
- GRCh38:
- Chr15:48247386
| SLC12A1 | G537A | Bartter disease type 1 | Uncertain significance (Feb 23, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr15:48536956
- GRCh38:
- Chr15:48244759
| SLC12A1 | C436Y | Bartter disease type 1 | Uncertain significance (Feb 23, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr15:48551420
- GRCh38:
- Chr15:48259223
| SLC12A1 | G689E | Bartter disease type 1 | Uncertain significance (Feb 6, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:48591379
- GRCh38:
- Chr15:48299182
| SLC12A1 | H1001Q | Bartter disease type 1 | Uncertain significance (Aug 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:48539164
- GRCh38:
- Chr15:48246967
| SLC12A1 | T504I | Bartter disease type 1 | Uncertain significance (Oct 19, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr15:48513160
- GRCh38:
- Chr15:48220963
| CTXN2-AS1, SLC12A1 | R199G | not provided, Bartter disease type 1 | Conflicting interpretations of pathogenicity (Jan 17, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr15:48513137
- GRCh38:
- Chr15:48220940
| CTXN2-AS1, SLC12A1 | I191N | Bartter disease type 1 | Likely pathogenic (Dec 12, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:48539625
- GRCh38:
- Chr15:48247428
| SLC12A1 | T551I | Bartter disease type 1 | Uncertain significance (May 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:48539626
- GRCh38:
- Chr15:48247429
| SLC12A1 | | not provided, Bartter disease type 1 | Likely benign (Jul 21, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:48551449
- GRCh38:
- Chr15:48259252
| SLC12A1 | D699N | not provided, Bartter disease type 1 | Benign/Likely benign (Jun 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:48541891
- GRCh38:
- Chr15:48249694
| SLC12A1 | | not provided, Bartter disease type 1 | Likely benign (Dec 28, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:48559809
- GRCh38:
- Chr15:48267612
| SLC12A1 | Q736K | Bartter disease type 1, not provided | Uncertain significance (Sep 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:48584054
- GRCh38:
- Chr15:48291857
| SLC12A1 | K985E | not provided, Bartter disease type 1 | Uncertain significance (Aug 31, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:48500310
- GRCh38:
- Chr15:48208113
| CTXN2-AS1, SLC12A1 | L132F | Bartter disease type 1, not provided | Uncertain significance (Feb 16, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:48591429
- GRCh38:
- Chr15:48299232
| SLC12A1 | P1018L | not provided, Bartter disease type 1 | Uncertain significance (Oct 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:48580264
- GRCh38:
- Chr15:48288067
| SLC12A1 | S885L | Bartter disease type 1, not provided | Uncertain significance (Apr 28, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:48537081
- GRCh38:
- Chr15:48244884
| SLC12A1 | G478R | not provided, Bartter disease type 1 | Conflicting interpretations of pathogenicity (Sep 2, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr15:48527089
- GRCh38:
- Chr15:48234892
| SLC12A1 | E368G | not provided, Bartter disease type 1 | Conflicting interpretations of pathogenicity (May 4, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr15:48577324
- GRCh38:
- Chr15:48285127
| SLC12A1 | Q836L | not provided, Bartter disease type 1 | Uncertain significance (Mar 7, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:48500034
- GRCh38:
- Chr15:48207837
| CTXN2-AS1, SLC12A1 | T40A | not provided, Bartter disease type 1 | Uncertain significance (Jul 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:48580692
- GRCh38:
- Chr15:48288495
| SLC12A1 | R951H | Bartter disease type 1, not provided | Uncertain significance (Feb 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:48595038
- GRCh38:
- Chr15:48302841
| SLC12A1 | L1086I | Bartter disease type 1, not provided | Uncertain significance (May 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:48536965
- GRCh38:
- Chr15:48244768
| SLC12A1 | R439Q | not provided, Bartter disease type 1 | Pathogenic/Likely pathogenic (Jun 23, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:48500139
- GRCh38:
- Chr15:48207942
| CTXN2-AS1, SLC12A1 | Q75* | not provided, Bartter disease type 1 | Pathogenic (Sep 6, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:48543952
- GRCh38:
- Chr15:48251755
| LOC126862123, SLC12A1 | T643fs | Bartter disease type 1 | Likely pathogenic (Jan 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:48548109
- GRCh38:
- Chr15:48255912
| SLC12A1 | | Bartter disease type 1 | Pathogenic (Oct 5, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr15:48500298
- GRCh38:
- Chr15:48208101
| CTXN2-AS1, SLC12A1 | R128* | not provided, Bartter disease type 1 | Pathogenic (Mar 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:48539652
- GRCh38:
- Chr15:48247455
| SLC12A1 | L560P | Bartter disease type 1 | Likely pathogenic (Oct 2, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:48580638-48580639
- GRCh38:
- Chr15:48288441-48288442
| SLC12A1 | W936fs | Bartter disease type 1 | Likely pathogenic (Sep 15, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr15:48580263
- GRCh38:
- Chr15:48288066
| SLC12A1 | S885P | Bartter disease type 1 | Uncertain significance (Feb 11, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:48561834
- GRCh38:
- Chr15:48269637
| SLC12A1 | | not provided, Bartter disease type 1 | Benign (Jul 15, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:48559826
- GRCh38:
- Chr15:48267629
| SLC12A1 | | not provided, Bartter disease type 1 | Likely benign (Nov 2, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:48593580
- GRCh38:
- Chr15:48301383
| SLC12A1 | | not provided, Bartter disease type 1 | Pathogenic/Likely pathogenic (May 8, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:48537004
- GRCh38:
- Chr15:48244807
| SLC12A1 | G452A | Bartter disease type 1, not provided | Uncertain significance (Dec 16, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:48559885
- GRCh38:
- Chr15:48267688
| SLC12A1 | R761Q | Bartter disease type 1 | Uncertain significance (Sep 27, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:48543859
- GRCh38:
- Chr15:48251662
| LOC126862123, SLC12A1 | G612R | Bartter disease type 1 | Likely pathogenic (Sep 27, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr15:48533801
- GRCh38:
- Chr15:48241604
| SLC12A1 | | Bartter disease type 1 | Uncertain significance (Jul 27, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr15:48548046
- GRCh38:
- Chr15:48255849
| SLC12A1 | V661M | not provided, Bartter disease type 1 | Uncertain significance (Apr 12, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:48512923
- GRCh38:
- Chr15:48220726
| SLC12A1 | Q171H | Inborn genetic diseases, not provided, Bartter disease type 1
| Uncertain significance (Apr 11, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:48543854-48543855
- GRCh38:
- Chr15:48251657-48251658
| LOC126862123, SLC12A1 | F611fs | Bartter disease type 1 | Uncertain significance (Sep 27, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr15:48577390
- GRCh38:
- Chr15:48285193
| SLC12A1 | R858L | not provided, Bartter disease type 1 | Uncertain significance (Sep 27, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:48561901
- GRCh38:
- Chr15:48269704
| SLC12A1 | Y781C | not provided, Bartter disease type 1 | Uncertain significance (Jun 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:48539121
- GRCh38:
- Chr15:48246924
| SLC12A1 | S490A | Bartter disease type 1 | Uncertain significance (Oct 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr15:48527103
- GRCh38:
- Chr15:48234906
| SLC12A1 | R373C | Bartter disease type 1 | Uncertain significance (Mar 11, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:48521468
- GRCh38:
- Chr15:48229271
| SLC12A1 | | not provided, Bartter disease type 1 | Conflicting interpretations of pathogenicity (Dec 18, 2021) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr15:48521421
- GRCh38:
- Chr15:48229224
| SLC12A1 | P254A | not provided, Bartter disease type 1 | Uncertain significance (Jul 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:48518783
- GRCh38:
- Chr15:48226586
| SLC12A1 | | Bartter disease type 1 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr15:48518760
- GRCh38:
- Chr15:48226563
| SLC12A1 | V239A | Bartter disease type 1 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr15:48595298
- GRCh38:
- Chr15:48303101
| SLC12A1 | | Bartter disease type 1 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr15:48577363
- GRCh38:
- Chr15:48285166
| SLC12A1 | E849G | Bartter disease type 1 | Uncertain significance (Mar 9, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:48577345
- GRCh38:
- Chr15:48285148
| SLC12A1 | A843V | Bartter disease type 1 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr15:48566833
- GRCh38:
- Chr15:48274636
| SLC12A1 | Q823P | Bartter disease type 1 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr15:48566770
- GRCh38:
- Chr15:48274573
| SLC12A1 | D802G | not provided, Bartter disease type 1, Inborn genetic diseases
| Uncertain significance (Apr 9, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:48559875
- GRCh38:
- Chr15:48267678
| SLC12A1 | D758H | Bartter disease type 1 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr15:48595122
- GRCh38:
- Chr15:48302925
| SLC12A1 | | Bartter disease type 1 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr15:48594988
- GRCh38:
- Chr15:48302791
| SLC12A1 | L1069W | Bartter disease type 1 | Uncertain significance (Jul 19, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:48594942
- GRCh38:
- Chr15:48302745
| SLC12A1 | | Bartter disease type 1 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr15:48559812
- GRCh38:
- Chr15:48267615
| SLC12A1 | A737T | Bartter disease type 1, not provided, Inborn genetic diseases
| Conflicting interpretations of pathogenicity (Sep 26, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr15:48559798
- GRCh38:
- Chr15:48267601
| SLC12A1 | M732K | Bartter disease type 1 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr15:48559748
- GRCh38:
- Chr15:48267551
| SLC12A1 | | Bartter disease type 1 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr15:48512873
- GRCh38:
- Chr15:48220676
| SLC12A1 | G155S | Bartter disease type 1, not provided | Uncertain significance (Aug 9, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:48512872
- GRCh38:
- Chr15:48220675
| SLC12A1 | | Bartter disease type 1, not provided | Conflicting interpretations of pathogenicity (Oct 28, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr15:48512844
- GRCh38:
- Chr15:48220647
| SLC12A1 | T145N | Bartter disease type 1 | Uncertain significance (Apr 27, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr15:48593518
- GRCh38:
- Chr15:48301321
| SLC12A1 | R1035S | Bartter disease type 1 | Uncertain significance (Jan 15, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr15:48584020
- GRCh38:
- Chr15:48291823
| SLC12A1 | I973M | Bartter disease type 1 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr15:48543928
- GRCh38:
- Chr15:48251731
| LOC126862123, SLC12A1 | E635K | Bartter disease type 1 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr15:48499975
- GRCh38:
- Chr15:48207778
| SLC12A1 | R20H | Bartter disease type 1, not provided | Conflicting interpretations of pathogenicity (Jun 18, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr15:48499849
- GRCh38:
- Chr15:48207652
| SLC12A1 | | Bartter disease type 1 | Likely benign (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr15:48596124
- GRCh38:
- Chr15:48303927
| SLC12A1 | | Bartter disease type 1 | Uncertain significance (Apr 27, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr15:48595944
- GRCh38:
- Chr15:48303747
| SLC12A1 | | Bartter disease type 1 | Likely benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr15:48595711
- GRCh38:
- Chr15:48303514
| SLC12A1 | | Bartter disease type 1 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr15:48595675
- GRCh38:
- Chr15:48303478
| SLC12A1 | | Bartter disease type 1 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr15:48595578
- GRCh38:
- Chr15:48303381
| SLC12A1 | | Bartter disease type 1 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr15:48595518
- GRCh38:
- Chr15:48303321
| SLC12A1 | | Bartter disease type 1 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr15:48580665
- GRCh38:
- Chr15:48288468
| SLC12A1 | R942T | Inborn genetic diseases, Bartter disease type 1 | Uncertain significance (Dec 16, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:48580625
- GRCh38:
- Chr15:48288428
| SLC12A1 | I929V | Bartter disease type 1 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr15:48580286
- GRCh38:
- Chr15:48288089
| SLC12A1 | | Bartter disease type 1 | Uncertain significance (Mar 16, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr15:48541773
- GRCh38:
- Chr15:48249576
| SLC12A1 | | not provided, Bartter disease type 1 | Uncertain significance (Oct 24, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:48539189
- GRCh38:
- Chr15:48246992
| SLC12A1 | | not provided, Bartter disease type 1 | Conflicting interpretations of pathogenicity (May 8, 2021) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr15:48539147
- GRCh38:
- Chr15:48246950
| SLC12A1 | | Bartter disease type 1 | Uncertain significance (Apr 27, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr15:48533808
- GRCh38:
- Chr15:48241611
| SLC12A1 | | not provided, Bartter disease type 1 | Benign/Likely benign (Oct 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:48533699
- GRCh38:
- Chr15:48241502
| SLC12A1 | | not provided, Bartter disease type 1 | Benign/Likely benign (Sep 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:48559841
- GRCh38:
- Chr15:48267644
| SLC12A1 | Y748fs | not provided, Bartter disease type 1 | Pathogenic (Sep 2, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:48521477
- GRCh38:
- Chr15:48229280
| CTXN2-AS1, SLC12A1 | | not provided, Bartter disease type 1 | Likely benign (Aug 17, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:48500331
- GRCh38:
- Chr15:48208134
| SLC12A1 | A139T | not provided, Bartter disease type 1 | Benign (Aug 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:48518739
- GRCh38:
- Chr15:48226542
| SLC12A1 | A232V | Bartter disease type 1, not provided | Benign/Likely benign (Oct 22, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:48500105
- GRCh38:
- Chr15:48207908
| CTXN2-AS1, SLC12A1 | | Bartter disease type 1, not provided | Benign/Likely benign (Oct 24, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:48551421
- GRCh38:
- Chr15:48259224
| SLC12A1 | | not provided, Bartter disease type 1 | Benign/Likely benign (Oct 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:48559884
- GRCh38:
- Chr15:48267687
| SLC12A1 | | not provided, Bartter disease type 1 | Likely benign (Nov 19, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:48591430
- GRCh38:
- Chr15:48299233
| SLC12A1 | | Bartter disease type 1, not provided | Conflicting interpretations of pathogenicity (Sep 29, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr15:48539526
- GRCh38:
- Chr15:48247329
| SLC12A1 | | Bartter disease type 1, not provided | Likely benign (Jun 26, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:48527147
- GRCh38:
- Chr15:48234950
| SLC12A1 | | not provided, Bartter disease type 1 | Conflicting interpretations of pathogenicity (Feb 7, 2018) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr15:48559763
- GRCh38:
- Chr15:48267566
| SLC12A1 | | not provided, Bartter disease type 1 | Benign/Likely benign (Oct 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:48580672-48580723
- GRCh38:
- Chr15:48288475-48288526
| SLC12A1 | | Bartter disease type 1 | Likely pathogenic (Apr 2, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr15:48566800
- GRCh38:
- Chr15:48274603
| SLC12A1 | I812R | not provided, Bartter disease type 1 | Uncertain significance (Oct 31, 2018) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:48500122
- GRCh38:
- Chr15:48207925
| CTXN2-AS1, SLC12A1 | C69Y | not provided, Bartter disease type 1 | Uncertain significance (Oct 31, 2018) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:48519315
- GRCh38:
- Chr15:48227118
| CTXN2-AS1, SLC12A1 | T223M | Bartter disease type 1 | Uncertain significance (May 3, 2020) | criteria provided, single submitter |